Bank of New York Mellon’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-787,979
| Closed | -$5.94M | – | 4368 |
|
|
2023
Q1 | $5.94M | Sell |
787,979
-7,106
| -0.9% | -$53.6K | ﹤0.01% | 2202 |
|
|
2022
Q4 | $8.05M | Buy |
795,085
+23,841
| +3% | +$242K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $7.63M | Buy |
771,244
+81,706
| +12% | +$808K | ﹤0.01% | 2064 |
|
|
2022
Q2 | $7.34M | Buy |
+689,538
| New | +$7.34M | ﹤0.01% | 2112 |
|
|
2021
Q4 | – | Sell |
-28,613
| Closed | -$573K | – | 4614 |
|
|
2021
Q3 | $573K | Sell |
28,613
-60,358
| -68% | -$1.21M | ﹤0.01% | 3729 |
|
|
2021
Q2 | $1.96M | Buy |
+88,971
| New | +$1.96M | ﹤0.01% | 2988 |
|